Results 21 to 30 of about 172,793 (249)

Falsified medicines in Africa

open access: yesThe Lancet Global Health, 2015
Tim Ziemer
doaj   +3 more sources

Falsified medicines in Africa: all talk, no action

open access: yesThe Lancet Global Health, 2014
تسبب الأدوية والمنتجات الطبية ذات الجودة الرديئة، سواء كانت دون المستوى المطلوب أو مزيفة، اعتلالًا يمكن تجنبه، ووفيات، ومقاومة للأدوية، وفقدان الثقة في الأنظمة الصحية، خاصة في البلدان منخفضة الدخل ومتوسطة الدخل .1-3 نبلغ عن تحليل دواءين مزيفين من أنغولا ونناقش الدروس التي يمكن أن يحملها هذا الاكتشاف.
Paul N Newton   +12 more
doaj   +4 more sources

Assessing knowledge, attitudes, and practices and demand-side interventions for combating substandard and falsified medicines: a scoping review [PDF]

open access: yesJournal of Pharmaceutical Policy and Practice
Background The proliferation of substandard and falsified medical products (SFM) poses a significant threat to public health globally. Despite rigorous surveillance and law enforcement efforts, risk of exposure to SFM is on the rise, notably through ...
Eishita Pal   +8 more
doaj   +2 more sources

Substandard and Falsified Medicines, Regulatory Capacity and Public Health: A Narrative Review With a Focus on Africa. [PDF]

open access: yesPublic Health Chall
Weak medicines regulation in Africa enables the circulation of substandard and falsified medicines, undermining treatment outcomes, accelerating antimicrobial resistance and eroding public trust. This narrative review synthesised 38 studies from 2000 to 2025, highlighting regulatory gaps, public health harms and regional disparities.
Vandy A   +8 more
europepmc   +2 more sources

Combatting Substandard and Falsified Medicines: A View from Rwanda [PDF]

open access: yesPLoS Medicine, 2013
Agnes Binagwaho and colleagues describe Rwanda's experience of pharmacovigilance for malaria and tuberculosis, and call for a global treaty and leadership by the World Health Organization to address the global manufacture and trade in substandard and falsified medicines.
Binagwaho, Agnes   +10 more
openaire   +7 more sources

Combating sale of counterfeit and falsified medicines online: a losing battle [PDF]

open access: yesFront Pharmacol, 2017
The rapid growth of technology has transformed many brick-and-mortar businesses into online businesses, and medicines are now being sold over the internet.
Al-Worafi, YM (15668852)   +6 more
core   +2 more sources

Brexit and the falsified medicines directive [PDF]

open access: yes, 2017
In order to help patients avoid being exposed to falsified medicines, the European Commission developed a series of measures to support patients in identifying licenced suppliers of pharmaceutical medicines, and suppliers to identify whether an end-user ...
Hibberd, Ralph
core   +5 more sources

Trade in substandard and falsified medicines [PDF]

open access: yes, 2022
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical
Nhomsai Hagen, Cathrin Hauk, Lutz Heide
openaire   +2 more sources

Falsified Medicines, a Crime without Punishment [PDF]

open access: yesInternational Journal of Medicine and Surgery, 2017
Falsified medicines are a global threat that does not stop growing. Its trafficking causes more deaths than malaria while being more profitable than drug smuggling.
Marc GENTILINI, Quentin DUTEIL
openaire   +2 more sources

Comprehensive Characterisation of the Ketoprofen-β-Cyclodextrin Inclusion Complex Using X-ray Techniques and NMR Spectroscopy

open access: yesMolecules, 2021
Racemic ketoprofen (KP) and β-cyclodextrin (β-CD) powder samples from co-precipitation (1), evaporation (2), and heating-under-reflux (3) were analysed using X-ray techniques and nuclear magnetic resonance (NMR) spectroscopy.
Katarzyna Betlejewska-Kielak   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy